Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.
Article
Google Scholar
Kutlu O, Kaleli HN, Ozer E. Molecular pathogenesis of nonalcoholic steatohepatitis- (NASH-) related hepatocellular carcinoma. Can J Gastroenterol Hepatol. 2018;2018:8543763.
Article
Google Scholar
Brown AL, Conrad K, Allende DS, Gromovsky AD, Zhang R, Neumann CK, et al. Dietary choline supplementation attenuates high-fat-diet-induced hepatocellular carcinoma in mice. J Nutr. 2020;150(4):775–83.
Article
Google Scholar
Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, et al. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity. Clin Gastroenterol Hepatol. 2017;15(10):1604–11.e1.
Article
Google Scholar
Younes R, Bugianesi E. NASH in lean individuals. Semin Liver Dis. 2019;39(1):86–95.
Article
CAS
Google Scholar
Fernández-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg. JHEP Rep. 2020;2(6):100167.
Article
Google Scholar
Vlock EM, Karanjit S, Talmon G, Farazi PA. Reduction of polyunsaturated fatty acids with tumor progression in a lean non-alcoholic steatohepatitis-associated hepatocellular carcinoma mouse model. J Cancer. 2020;11(19):5536–46.
Article
CAS
Google Scholar
Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751–9.
Article
Google Scholar
Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, Melnick A, et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 2012;13(10):R87.
Article
Google Scholar
Wang HQ, Tuominen LK, Tsai CJ. SLIM: a sliding linear model for estimating the proportion of true null hypotheses in datasets with dependence structures. Bioinformatics. 2011;27(2):225–31.
Article
Google Scholar
UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–D9.
Article
Google Scholar
O'Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733–45.
Article
CAS
Google Scholar
Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(D1):D419–D26.
Article
CAS
Google Scholar
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25–9.
Article
CAS
Google Scholar
The Gene Ontology resource. Enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325–d34.
Article
Google Scholar
Zhang Y, Xie L, Gunasekar SK, Tong D, Mishra A, Gibson WJ, et al. SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis. Nat Cell Biol. 2017;19(5):504–17.
Article
CAS
Google Scholar
Henley KD, Gooding KA, Economides AN, Gannon M. Inactivation of the dual bmp/Wnt inhibitor Sostdc1 enhances pancreatic islet function. Am J Physiol Endocrinol Metab. 2012;303(6):E752–61.
Article
CAS
Google Scholar
Andrade S, Morais T, Sandovici I, Seabra AL, Constância M, Monteiro MP. Adipose tissue epigenetic profile in obesity-related Dysglycemia - a systematic review. Front Endocrinol (Lausanne). 2021;12:681649.
Article
Google Scholar
Hair BY, Troester MA, Edmiston SN, Parrish EA, Robinson WR, Wu MC, et al. Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors. Cancer Epidemiol Biomark Prev. 2015;24(3):580–6.
Article
CAS
Google Scholar
Masgras I, Sanchez-Martin C, Colombo G, Rasola A. The chaperone TRAP1 as a modulator of the mitochondrial adaptations in Cancer cells. Front Oncol. 2017;7:58.
Article
Google Scholar
Li B, Xu T, Liu C, Meng G, Sun Y, Qian L, et al. Liver-enriched genes are associated with the prognosis of patients with hepatocellular carcinoma. Sci Rep. 2018;8(1):11197.
Article
Google Scholar
Skawran B, Steinemann D, Weigmann A, Flemming P, Becker T, Flik J, et al. Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. Mod Pathol. 2008;21(5):505–16.
Article
CAS
Google Scholar
Vastrad B, Vastrad C. Bioinformatics analysis of differentially expressed genes in non alcoholic fatty liver disease using next generation sequencing data. bioRxiv. 2021:2021.12.16.472893. https://doi.org/10.1101/2021.12.16.472893.
Liu Y, Zhang JB, Qin Y, Wang W, Wei L, Teng Y, et al. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability. Hepatology. 2013;58(2):692–705.
Article
CAS
Google Scholar
Wang X, Cheng Y, Yan LL, An R, Wang XY, Wang HY. Exploring DNA methylation profiles altered in cryptogenic hepatocellular carcinomas by high-throughput targeted DNA methylation sequencing: a preliminary study for cryptogenic hepatocellular carcinoma. Onco Targets Ther. 2020;13:9901–16.
Article
CAS
Google Scholar
Yang CK, Wang XK, Liao XW, Han CY, Yu TD, Qin W, et al. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma. PLoS One. 2017;12(8):e0182208.
Article
Google Scholar
Chen J, Chen Z, Huang Z, Yu H, Li Y, Huang W. Formiminotransferase Cyclodeaminase suppresses hepatocellular carcinoma by modulating cell apoptosis, DNA damage, and phosphatidylinositol 3-kinases (PI3K)/Akt signaling pathway. Med Sci Monit. 2019;25:4474–84.
Article
CAS
Google Scholar
Liang Q, Tan C, Xiao F, Yin F, Liu M, Lei L, et al. Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma. Bosn J Basic Med Sci. 2021;21(6):712–23.
Google Scholar
Wang WP, Gao HY. Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity. Exp Ther Med. 2018;15(1):641–8.
CAS
Google Scholar
Drozdov I, Bornschein J, Wex T, Valeyev NV, Tsoka S, Malfertheiner P. Functional and topological properties in hepatocellular carcinoma transcriptome. PLoS One. 2012;7(4):e35510.
Article
CAS
Google Scholar
Mahajan N, Khare P, Kondepudi KK, Bishnoi M. TRPA1: pharmacology, natural activators and role in obesity prevention. Eur J Pharmacol. 2021;912:174553.
Article
CAS
Google Scholar
Busque SM, Stange G, Wagner CA. Dysregulation of the glutamine transporter Slc38a3 (SNAT3) and ammoniagenic enzymes in obese, glucose-intolerant mice. Cell Physiol Biochem. 2014;34(2):575–89.
Article
CAS
Google Scholar
Escobedo N, Proulx ST, Karaman S, Dillard ME, Johnson N, Detmar M, et al. Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice. JCI Insight. 2016;1(2):e85096.
Article
Google Scholar
Dogan H, Shu J, Hakguder Z, Xu Z, Cui J. Elucidation of molecular links between obesity and cancer through microRNA regulation. BMC Med Genet. 2020;13(1):161.
Google Scholar
Huckins LM, Hatzikotoulas K, Southam L, Thornton LM, Steinberg J, Aguilera-McKay F, et al. Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry. 2018;23(5):1169–80.
Article
CAS
Google Scholar
Dreval K, Tryndyak V, de Conti A, Beland FA, Pogribny IP. Gene expression and DNA methylation alterations during non-alcoholic steatohepatitis-associated liver carcinogenesis. Front Genet. 2019;10:486.
Article
CAS
Google Scholar
Kuramoto J, Arai E, Tian Y, Funahashi N, Hiramoto M, Nammo T, et al. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. Carcinogenesis. 2017;38(3):261–70.
Article
CAS
Google Scholar
Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, et al. DNA methylation Cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150.
Article
CAS
Google Scholar
Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853–9.
Article
CAS
Google Scholar
Hymel E, Vlock E, Fisher KW, Farazi PA. Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice. PLoS One. 2022;17(8):e0272623.
Article
CAS
Google Scholar
Hotta K, Kitamoto A, Kitamoto T, Ogawa Y, Honda Y, Kessoku T, et al. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease. Sci Rep. 2018;8(1):13567.
Article
Google Scholar
Gundamaraju R, Lu W, Manikam R. CHCHD2: the power House's potential prognostic factor for Cancer? Front Cell Dev Biol. 2020;8:620816.
Article
Google Scholar
Yao Y, Su J, Zhao L, Li R, Liu K, Wang S. CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients. J Cancer. 2019;10(27):6822–8.
Article
CAS
Google Scholar
Liu H, Zhang Y, Li L, Cao J, Guo Y, Wu Y, et al. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Molecular Therapy - Oncolytics. 2021;20:240–64.
Article
CAS
Google Scholar
Udali S, Guarini P, Ruzzenente A, Ferrarini A, Guglielmi A, Lotto V, et al. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin Epigenetics. 2015;7:43.
Article
Google Scholar
Shorthouse D, Rahrmann E, Kosmidou C, Greenwood B, Hall M, Devonshire G, Gilbertson R, Fitzgerald R, Hall B. KCNQ gene family members act as both tumor suppressors and oncogenes in gastrointestinal cancers. bioRxiv. 2020:2020.03.10.984039.
Chen B, Liao Z, Qi Y, Zhang H, Su C, Liang H, et al. miR-631 inhibits intrahepatic metastasis of hepatocellular carcinoma by targeting PTPRE. Front Oncol. 2020;10:565266.
Article
Google Scholar
Liu L, Wu S, Yang Y, Cai J, Zhu X, Wu J, et al. SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation. Cell Biosci. 2016;6:24.
Article
Google Scholar
Jiang M, Zeng Q, Dai S, Liang H, Dai F, Xie X, et al. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles. Mol Med Rep. 2017;15(1):380–6.
Article
CAS
Google Scholar
Bian J, Long J, Yang X, Xu Y, Lu X, Guan M, et al. Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma. Ann Transl Med. 2021;9(9):765.
Article
CAS
Google Scholar
De Giorgi V, Buonaguro L, Worschech A, Tornesello ML, Izzo F, Marincola FM, et al. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One. 2013;8(2):e56153.
Article
Google Scholar
Shen J, Tsoi H, Liang Q, Chu ES, Liu D, Yu AC, et al. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. Oncogene. 2016;35(49):6271–80.
Article
CAS
Google Scholar
Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, et al. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma. 2018;5:61–73.
Article
CAS
Google Scholar
Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68–75.
Article
Google Scholar
He S, Tang S. WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.
Article
CAS
Google Scholar
Wong AM, Ding X, Wong AM, Xu M, Zhang L, Leung HH-W, et al. Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion. J Hepatol. 2022;77(2):410–23.
Article
CAS
Google Scholar
Jin N, George TL, Otterson GA, Verschraegen C, Wen H, Carbone D, et al. Advances in epigenetic therapeutics with focus on solid tumors. Clin Epigenetics. 2021;13(1):83.
Article
CAS
Google Scholar